The global viral vector & plasmid manufacturing market size reached USD 517.4 Million in 2021 and is expected to register a revenue CAGR of 14.3% during the forecast period, according to the latest analysis by Emergen Research.
The global viral vector & plasmid manufacturing market size reached USD 517.4 Million in 2021 and is expected to register a revenue CAGR of 14.3% during the forecast period, according to the latest analysis by Emergen Research. The increasing demand for advanced gene therapy treatments and the rising prevalence of genetic disorders are the major factors driving the growth of this market. In addition, the growing government initiatives to promote research & development activities in the field of gene therapy is anticipated to fuel market growth over the forecast period.
Viral Vector is a potent tool used for gene delivery and manipulation. The viruses, due to their ability to infect cells and deliver genes inside the host cells, are used as a carrier or vector for the therapeutic genes. These vectors help in treating several genetic disorders by replacing the mutated gene with a healthy copy of the gene.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/14
Plasmid Manufacturing is the process of making copies of a circular piece of DNA. Bacteria and archaea often have plasmids, which are extra pieces of DNA that do not make up the bacterial chromosome. The term usually refers to artificial plasmids made in the laboratory for research purposes. However, it can also refer to natural plasmids that occur in some bacteria.
Substantial investments are anticipated from key players in the viral vector & plasmid manufacturing market to upgrade their production facilities and capacities. Furthermore, expansions are another significant strategy adopted by companies to sustain in the competitive landscape of the viral vector & plasmid manufacturing market. For instance, in 2019, Wuxi AppTec (China) announced the expansion of its viral vector facility in Suzhou, China. The expansion of the facility was aimed at addressing the increasing demand for lentiviral vectors and other virus-based therapeutics from academia and industry globally. Such expansions demonstrate that key companies are focusing on meeting the rising global demand for viral vector-based therapeutics.
Further key findings from the report suggest
- Key players in the market include Brammer Bio, Cobra Biologics, Cell, and Gene Therapy Catapult, FinVector Vision Therapies, Fujifilm Diosynth Biotechnologies, MassBiologics, SIRION Biotech, Merck KGaA Inc., Thermo Fisher Scientific, and Unique NV, among others.
- In December 2019, GMP Contract Manufacturing Business to launch Genopis (GENstor Operations Information System) for enhanced customer collaboration and data accessibility.
- In February 2019, CMC Biologics A/S announced that it has signed an agreement with GSK to provide scale-up and commercial manufacturing of a viral vector-based gene therapy product using CMC Biologics’ proprietary iCELLis Nano platform.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/viral-vector-and-plasmid-manufacturing-market
- In September 2018, Merck KGaA (Germany) announced the expansion of its viral vector manufacturing capabilities by installing two new 1,000-liter single-use bioreactors at its Jena site in Germany. This investment will further strengthen the company’s position as a CDMO for adeno-associated virus (AAV) and lentivirus vectors.
- The plasmid manufacturing segment accounted for the largest share of the market in 2021 and is expected to maintain its leading position during the forecast period. The increasing demand for plasmid-based gene therapy products is the major factor driving the growth of this segment.
- The adeno-associated virus (AAV) segment held the largest share of the viral vector & plasmid manufacturing market in 2021 and is expected to maintain its leading position over the forecast period. The increasing use of AAV-based gene therapy products in the treatment of genetic disorders is the major factor driving the growth of this segment.
- The clinical applications segment accounted for the largest share of the viral vector & plasmid manufacturing market in 2021 and is expected to maintain its leading position during the forecast period. The increasing use of viral vector & plasmid-based gene therapy products in the treatment of cancer and genetic disorders is the major factor driving the growth of this segment.
- North America held the largest share of the viral vector & plasmid manufacturing market in 2021 and is expected to maintain its leading position over the forecast period. The presence of a large number of key market players and the increasing government initiatives to promote research & development activities in the field of gene therapy are the major factors driving the growth of this market.
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/14
For the purpose of this report, Emergen Research has segmented into the global Viral Vector and Plasmid Manufacturing Market on the basis of Vector Type, Workflow, Disease, Application, End-User, and region:
Vector Type Outlook (Revenue: USD Billion; 2017-2027)
- Adenovirus
- Retrovirus
- Plasmid DNA
- AAV
- Lentivirus
- Others
Workflow Outlook (Revenue: USD Billion; 2017-2027)
- Upstream Processing
- Downstream Processing
Disease Outlook (Revenue: USD Billion; 2017-2027)
- Cancer
- Genetic Disorders
- Infectious Diseases
- Others
Application Outlook (Revenue: USD Billion; 2017-2027)
- Antisense & RNAi
- Gene Therapy
- Cell Therapy
- Vaccinology
End-User Outlook (Revenue: USD Billion; 2017-2027)
- Pharmaceutical and Biopharmaceutical Companies
- Research Institutes
Regional Outlook (Revenue: USD Billion; 2017-2027)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- BENELUX
- Asia Pacific
- China
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- MEA
- Saudi Arabia
- UAE
- Rest of MEA
Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/14
Explore More Reports Emergen Research:
Healthcare Business Intelligence Market
Healthcare IT Integration Market
Operating Room Integration Systems Market
Medical Device Connectivity Market
Patient Registry Software Market
Automotive Intelligent Lighting Market
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
14671 110 Avenue, Surrey, British Columbia, V3R2A9
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Press Release: https://www.emergenresearch.com/press-release/global-viral-vector-and-plasmid-manufacturing-market
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Latest Published Titles Smart Cities Market | Smart Learning Market
Trending Titles Humanoid Robot Market | Incident Response Market